Alcohol-aware risk stratification and subtype-specific care pathways across metabolic dysfunction-associated steatotic liver disease, metabolic dysfunction and alcohol-associated liver disease, and alcohol-associated liver disease. [PDF]
Lee HY, Yoon EL, Jun DW.
europepmc +1 more source
Predicting steroid response in acute alcohol-associated hepatitis: Beyond biomarkers of alcohol consumption. [PDF]
Zhang JW.
europepmc +1 more source
Evaluating a drink-counting and a breathalyzer-coupled app for monitoring alcohol use: A comparison with timeline followback and peth biomarker. [PDF]
Ă–sth J +4 more
europepmc +1 more source
Psychosocial Interventions for Alcohol Use Disorder: A Review of Efficacy, Mechanisms, and Clinical Implications. [PDF]
Peng J, Wei L, Liang Y, Tan Y.
europepmc +1 more source
Liver Transplantation for Alcohol-Related Liver Disease in 2026: Phenotypes, Selection, and Post-Transplant Care. [PDF]
Ferrarese A +7 more
europepmc +1 more source
MDMA-assisted PTSD and Alcohol Therapy Trial (MPATHY): study protocol for a double-blind, randomised, controlled outpatient trial of MDMA-assisted integrated exposure-based therapy for comorbid post-traumatic stress disorder and alcohol use disorder. [PDF]
Morley KC +10 more
europepmc +1 more source
Liver and atherosclerotic risks associated with cryptogenic steatotic liver disease: are the new diagnostic criteria justified? [PDF]
Rasool D, Ahmad S, Visaria A, Abbas GH.
europepmc +1 more source
Novel educational video module about alcohol use disorder increases treatment rates and decreases return to alcohol use. [PDF]
Twohig P +10 more
europepmc +1 more source
Multimodal Nutraceutical and Psychological Intervention for GGT Reduction in Individuals with Alcohol Use Disorder. [PDF]
Diana NS, Monica T, Florina G.
europepmc +1 more source

